1. The effect of biologically synthesized and purified fluorocitrate on the metabolism of tricarboxylate anions by isolated rat liver mitochondria was investigated, in relation to the claim by Eanes et al. (1972) that this fluoro compound inhibits the tricarboxylate carrier at concentrations at which it has little effect on the aconitate hydratase activity. 2. That the inhibitory action of fluorocitrate is at the level of the aconitate hydratase and not at the level of the tricarboxylate carrier is indicated by the following findings. Although the oxidation of citrate and cis-aconitate, but not that of isocitrate, was inhibited by fluorocitrate, the exchange of internal citrate for external citrate or L-malate was not. Had the tricarboxylate carrier been affected, these latter exchange reactions would have been inhibited. 3. By using aconitate hydratase solubilized from mitochondria it was found that with citrate as substrate the inhibition by fluorocitrate was partially competitive (K1 = 3.4
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It is well established, mainly as a result of the early observations of Peters and his co-workers (Lotspeich et al., 1952; Morrison & Peters, 1954) that fluorocitrate is a potent inhibitor of aconitate hydratase (EC 4.2.1.3) derived from rat liver mitochondria. With this inhibitor, K1 values of 300pM (GuarrieraBobyleva & Buffa, 1969) , 64,M (Eanes et al., 1972) and 2.5,uM (Fanshier et al., 1964) have been reported for inhibition of the enzyme reaction for the conversion of citrate into cis-aconitate. The variation in K1 values may reasonably be attributed, at least in part, to a difference in the proportion of the inhibiting isomer of fluorocitrate, (-)-erythro-fluorocitrate, contained in the fluorocitrate samples used by these workers (Dummel & Kun, 1969) .
However, Eanes et al. (1972) have proposed that the inhibition of citrate oxidation by fluorocitrate is not at the level of aconitate hydratase, but at the level of the tricarboxylate carrier (see Chappell, 1968) . Their interpretation is based on the observation that concentrations of fluorocitrate that abolish isocitrate efflux from whole mitochondria with citrate as substrate have no effect on isocitrate formation when mitochondrial structure is disrupted with Triton X-100.
Fluorocitrate is often added to experiments on the tricarboxylate carrier to inhibit metabolism of citrate through aconitate hydratase (Chappell, 1968 Rat liver mitochondria. These were prepared from albino Wistar rats by the method of Chappell & Hansford (1972) .
Protein. This was assayed by a modified biuret method, including deoxycholate to solubilize the mitochondria. A standard curve was constructed by using bovine serum albumin (fraction V).
Oxygen uptake. This was followed in a Clark-type oxygen electrode as described by Chappell (1961 Chappell ( , 1964 .
Citrate spaces. The method is basically the same as that described by Chappell (1968 The samples were then spun in an Eppendorf 3200 bench centrifuge for 4min. Portions (0.5ml) of the supernatant were added to equal amounts of 3% (w/v) HCl04 and the pellets were resuspended in water and 3% (w/v) HCl04 and re-centrifuged. Samples of the acidified pellet and supernatant fractions were counted for radioactivity in a Packard Tri-Carb liquid-scintillation counter (with an internal standard), by using a toluene scintillator containing in 2 litres, 800ml of methoxyethanol, 160g of naphthalene and 12g of 5-(4-biphenylyl)-2-(4-t-butylphenyl)-1-oxa-3,4-diazole.
[ Robinson et al. (1970) , but N-ethylmaleimide was used and the experiment was carried out at 20°C. The medium contained 75mM-KCI, 20mM-Tris-HCl, pH7.4, rotenone (1,tg/ml), antimycin A (0.5,ug/ml), l0mM-ATP, 20mM-KHCO3,5 mM-2-oxoglutarate, 10,uCi of H14C03-, 1 mM-potassium phosphate and 1 mM-malate.
The probable mechanism is: (e) glutamate Mitochondria (4mg of protein) were suspended in 120mM-KCI, 20mM-Tris-HCl, pH7.4, 25mM-potassium phosphate; the concentration of substrates was 3.13mM, except for 2-oxoglutarate and glutamate, which were 5mM. In all cases 1 mM-malate was present. In the experiments with fluorocitrate, the mitochondria were preincubated with fluorocitrate (1 uM) for 2mm before addition of substrate(s), then 1 mm further was allowed before simultaneous addition of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (2,uM) and ADP (0.25mM). Rates are in ng-atoms of 0/min per mg of protein.
, No fluorocitrate; ----, 1 ,uM-fluorocitrate.
1973 source of carbon skeleton is that metabolism of labelled citrate during later experiments produces labelled CO2 which is removed during the experiment, whereas from pyruvate the label can become dispersed among other metabolites.
[14C]Citrate exchange. Rat liver mitochondria (3-4mg of protein) loaded with [14C]citrate were pipetted into tubes containing lml of 120mM-KCl, 20mM-Tris-HCl, pH7.4, rotenone (10,ug), antimycin A (5,utg) and 2mM-N-ethyimaleimide and preincubated in this medium with fluorocitrate (2.5tkM) for 2min where appropriate. To exchange the citrate, 2min incubation with malate (2.3mM or 6.6mM) or citrate (6.6mM) was allowed in the presence and absence of fluorocitrate. Separation and determination of radioactivity was carried out as described for 'citrate spaces'.
Results and Discussion

Oxidation of tricarboxylic acids
The effect of 1 /tM-fluorocitrate on oxygen uptake by mitochondria in the presence of citrate, cisaconitate and isocitrate (substrates for the tricarboxylate carrier) and by 2-oxoglutarate and glutamate was investigated as shown in Fig. 1 . The rate of oxidation uncoupled by carbonyl cyanide p-trifluoromethoxyphenylhydrazone (2pM) was measured I min i in the presence ofADP (0.25mM) to activate the mitochondrial isocitrate dehydrogenase (EC 1.1.1.41).
The uncoupled oxidation of citrate (3.13mM) was inhibited by 60% in the presence of fluorocitrate, whereas that of cis-aconitate (3.13mM) was inhibited by 50%. In both cases subsequent addition of isocitrate caused a high rate of oxygen utilization, although this was not as high as with isocitrate alone. However, uncoupled oxidation of isocitrate (6.25mM-DL mixture) was not inhibited by fluorocitrate. The difference between rates of isocitrate oxidation in the presence and absence of citrate or cis-aconitate is probably due to competition for the tricarboxylate carrier between isocitrate and citrate or cis-aconitate. During mitochondrial oxidation citrate and cisaconitate are substrates for aconitate hydratase, but isocitrate, 2-oxoglutarate and glutamate are not. This would therefore suggest that fluorocitrate has no effect on the tricarboxylate carrier and that the inhibition of the rates of citrate and cis-aconitate oxidation is due to inhibition of the aconitate hydratase reactions. 2-Oxoglutarate and glutamate enter the mitochondrion by different carriers (Chappell, 1968) and as predicted fluorocitrate had no effect on their rates of uncoupled oxidation.
No inhibition by fluorocitrate was demonstrated when it was added after substrate (not shown); this is probably due to competition between substrate and inhibitor for the carrier. Effect offluorocitrate on reduction ofmitochondrial nicotinamide nucleotides Mitochondria (6mg of protein) were suspended in 2.5 ml of a medium containing 120mM-KCI, 20mM-Tris-HCl pH7.4, and 2,uM-carbonyl cyanide p-trifluoromethoxyphenylhydrazone, at 30°C. NAD(P)H formation was followed at 340-373nm. After 10-15min 0.25mg of antimycin A/ml and 2mM-Tris-phosphate, pH7.4, were added, together with 2/tM-fluorocitrate, where present. After 2min substrate was added as shown. Additions: 2mM-citrate, 2mM-cis-aconitate, 2mM-DL-isocitrate, 10mM-glutamate, 0.4mM-malate (all as potassium salts).
, No fluorocitrate present;
, 2,tM-fluorocitrate present.
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Reduction of mitochondrial nicotinamide nucleotides Mitochondria were depleted of endogenous substrates by incubation for 10-15min with uncoupler carbonyl cyanide p-trifluoromethoxyphenylhydrazone, and then the respiratory chain was blocked with antimycin A. Under these conditions the addition of substrate anions has little effect on the redox state of the intra-mitochondrial nicotinamide nucleotides. Subsequent addition of activators of transport (0.4mM-malate for tricarboxylic acids) causes reduction of internal NAD(P)+, which was monitored at 340-373nm on a double-beam spectrophotometer (Chappell, 1968) . The results are shown in Fig. 2 
Swelling of mitochondria
A decrease in E610 of mitochondria suspended in iso-osmotic solutions of NH4+ salts indicates permeation of the mitochondria by the anion (Chappell, 1968 Isocitrate efflux andformation Aconitate hydratase will catalyse the conversion of citrate or cis-aconitate into isocitrate; added citrate and cis-aconitate will therefore exchange on the tricarboxylate carrier with the isocitrate formed inside the mitochondria (III, Scheme 1). Table 3 shows the results of experiments in which isocitrate produced was coupled to external NADPH formation by added isocitrate dehydrogenase (EC 1.1.1.42) and the rates of reduction of NADP+ were measured at 340-373nm on a double-beam spectrophotometer.
The results for 1 mM-citrate or cis-aconitate as substrate confirm those of Eanes et al. (1972) , although we could not show complete inhibition, in agreement with Peters & Shorthouse (1970) . In contrast to Eanes et al. (1972) we found that addition of Triton X-100 diminished but did not abolish the inhibition by fluorocitrate. Similar results were obtained with 0.5mM substrate.
When mitochondria were sonicated (six 15s bursts at 4°C) and the fragments removed by centriVol. 134 Table 3 for cis-aconitate and Triton may be less reliable. A more detailed investigation of the kinetics of this system was made. Fig. 3 shows substrate inhibition of aconitate hydratase by fluorocitrate at citrate concentrations greater than 1 mM; this is lower than the value of 2-3mm taken from the results of Fanshier et al. (1964) . These workers, using concentrations of citrate greater than 2mM, and 1lOpM-and 1OOUM-fluorocitrate, estimated a Kg for (-)-erythro-fluorocitrate of 2.5 x 10-6M. Fig. 3 shows our results for these conditions, giving an apparent K, of 6 x 10-7M.
However, since substrate inhibition at these concentrations of citrate is marked, these values are unreliable. Consequently we have repeated this work at lower substrate concentrations. Addition of 1 mmisocitrate caused a rate of reduction five times that of the highest rate recorded in these experiments, showing that the assay system was not limiting. Fig. 4 is a Lineweaver-Burk plot showing the rate offormation ofisocitrate by lysed mitochondria, with citrate as substrate. The Km for citrate in intact mitochondria is 2.0 x 10-4M and in Triton-treated mitochondria it is 2.2 x 10-4M, agreeing closely with the value of 2 x 10-4M found by Henson & Cleland (1967) using ox liver. Fig. 4 indicates competitive inhibition by fluorocitrate; however, plots of l/v against inhibitor concentration were curved, indicating that the inhibition was partially competitive. The values of apparent Km in the presence of fluorocitrate obtained from Fig. 4 were therefore used in the appropriate equation (Dixon & Webb, 1964) . This gave consistent values of K, at different fluorocitrate concentrations. In intact mitochondria the K, is 1.2 x 10-8M; Table 3 . o, Whole mitochondria; *, whole mitochondria+50nM-fluorocitrate; A, lysed mitochondria; A, lysed mitochondria+50nM-fluorocitrate.
in lysed mitochondria it is 3.4 x 10-8 M. The values of Vmax. were 8.7 and 24.3 nmol of NADPH formed/min per mg of protein respectively.
Similar experiments with cis-aconitate as substrate (see Fig. 5 ) gave values of Km of 1.2 x 10-4M and 1.1 X 10-4M for intact and lysed mitochondria respectively, agreeing with the value of 9.0 x 10-5M found by Tomizawa (1953) with rabbit liver. In this case fluorocitrate inhibition appeared to be noncompetitive; again plots of l/v against inhibitor concentration were curved, indicating partial non-competitive inhibition. Substitution in the appropriate equation (Dixon & Webb, 1964) gave consistent values ofK1. The K, and Vm.x. for intact mitochondria were 5.8 x 10-8M and 26.9nmol of NADPH formed/ min per mg of protein respectively, and for Tritontreated mitochondria they were 3.0 x 1O-8M and 79.6nmol of NADPH formed/min per mg of protein respectively.
The values of K, reported here are very much lower than the values in the literature. The types of inhibition we have observed agree with those reported by Vol. 134 Fanshier et al. (1964) and J. J. Villafranca (unpublished work, quoted by Glusker, 1971) . Eanes et al. (1972) propose that fluorocitrate inhibits the tricarboxylate carrier, on the basis of three observations. The K1 for inhibition of isocitrate formation from citrate is very much lower in intact mitochondria than that for aconitate hydratase; the concentrations of fluorocitrate which inhibit 100 % in intact mitochondria do not inhibit isocitrate formation in broken mitochondria; and the activation of the tricarboxylate carrier by fluoromalate is abolished by fluorocitrate.
We propose that their interpretation is incorrect because we find that the values of K1 for intact and broken mitochondria are the same, and the rate of isocitrate formation in broken mitochondria is inhibited by the low fluorocitrate concentrations used by Eanes et al. (1972) , in spite of the claim to the contrary in the text. Activation of isocitrate efflux by fluoromalate would be abolished if aconitate hydratase was inhibited, since the tricarboxylate carrier is not rate-limiting. For experimental details see Table 3 . o, Whole mitochondria; *, whole mitochondria+50nm-fluorocitrate; A, lysed mitochondria; *, lysed mitochondria +500nm-fluorocitrate.
We therefore propose that fluorocitrate does not inhibit the tricarboxylate carrier, and that the results of Eanes et al. (1972) can be adequately explained by inhibition of aconitate hydratase.
